Short Interest in Definitive Healthcare Corp. (NASDAQ:DH) Drops By 23.2%

Definitive Healthcare Corp. (NASDAQ:DH) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 2,248,253 shares, a drop of 23.2% from the December 15th total of 2,928,539 shares. Based on an average trading volume of 774,861 shares, the short-interest ratio is currently 2.9 days. Approximately 1.9% of the company’s shares are sold short. Approximately 1.9% of the company’s shares are sold short. Based on an average trading volume of 774,861 shares, the short-interest ratio is currently 2.9 days.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DH. Wall Street Zen downgraded shares of Definitive Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, December 28th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, October 8th. Morgan Stanley reiterated an “underperform” rating and issued a $3.50 target price on shares of Definitive Healthcare in a report on Thursday, December 18th. Canaccord Genuity Group dropped their price target on Definitive Healthcare from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Monday, November 10th. Finally, Barclays reduced their price objective on Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a research note on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, three have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Definitive Healthcare has an average rating of “Hold” and an average price target of $3.94.

Institutional Investors Weigh In On Definitive Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in Definitive Healthcare in the 2nd quarter valued at about $32,000. Farther Finance Advisors LLC acquired a new position in shares of Definitive Healthcare in the second quarter worth about $33,000. Savant Capital LLC purchased a new position in Definitive Healthcare in the second quarter valued at about $45,000. SG Americas Securities LLC acquired a new stake in Definitive Healthcare during the 4th quarter valued at approximately $46,000. Finally, Los Angeles Capital Management LLC purchased a new stake in Definitive Healthcare during the 2nd quarter worth approximately $51,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Down 1.6%

Shares of DH traded down $0.04 during midday trading on Friday, reaching $2.39. 245,366 shares of the company were exchanged, compared to its average volume of 496,620. Definitive Healthcare has a 1-year low of $2.15 and a 1-year high of $5.68. The stock has a 50-day moving average price of $2.59 and a 200-day moving average price of $3.31. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.41. The company has a market cap of $337.85 million, a price-to-earnings ratio of -1.43 and a beta of 1.60.

Definitive Healthcare (NASDAQ:DH) last announced its earnings results on Thursday, November 6th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.06 by $0.01. The business had revenue of $60.05 million for the quarter, compared to the consensus estimate of $59.51 million. Definitive Healthcare had a positive return on equity of 3.30% and a negative net margin of 77.88%.Definitive Healthcare has set its FY 2025 guidance at 0.230-0.240 EPS and its Q4 2025 guidance at 0.050-0.060 EPS. Research analysts expect that Definitive Healthcare will post 0.16 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.